PROCEPT BioRobotics (PRCT) Current Assets (2020 - 2026)

PROCEPT BioRobotics (PRCT) has 7 years of Current Assets data on file, last reported at $428.0 million in Q1 2026.

• On a quarterly basis, Current Assets fell 8.11% year-over-year to $428.0 million in Q1 2026; TTM through Mar 2026 was $428.0 million, a 8.11% decrease from a year earlier, with the FY2025 full-year figure at $450.4 million, down 6.53% from the prior year.
• Current Assets for Q1 2026 stood at $428.0 million, down from $450.4 million in the prior quarter.
• Over the last five years, Current Assets for PRCT reached as high as $481.8 million in Q4 2024 and fell as low as $230.0 million in Q2 2023.
• Historically, Current Assets has averaged $357.4 million across 5 years, with a median of $329.2 million in 2024.
• Across the five-year window, Current Assets retreated 22.9% in 2023 and jumped 42.3% in 2025, its largest moves.
• Year by year, Current Assets stood at $272.6 million in 2022, then grew by 28.59% to $350.6 million in 2023, then surged by 37.45% to $481.8 million in 2024, then slipped by 6.53% to $450.4 million in 2025, then slipped by 4.96% to $428.0 million in 2026.
• Per Business Quant data, the three most recent Current Assets figures were $428.0 million in Q1 2026, $450.4 million in Q4 2025, and $454.8 million in Q3 2025.